Meet Kiwi shot putter Valerie Adams who swung back to action at 36 after two children and three critical abdominal surgeries to win an Olympic Bronze
The University of Oxford and drug manufacturer AstraZeneca have applied to the UK health regulator for permission to roll out their Covid-19 vaccine, Health Minister Matt Hancock said on Wednesday.
"I'm delighted to be able to tell you that the Oxford AstraZeneca vaccine developed here in the UK has submitted its full data package to the MHRA for approval," he said.
The vaccine developed by could be approved for use “just after” Christmas, according to a scientific government adviser.
Also read: UK imposes more lockdowns as new Covid variant causes record cases
Professor Sir John Bell, an Oxford academic and member of the government’s Scientific Advisory Group for Emergencies, said he had “no concerns” over the candidate, which is still being reviewed by the UK’s Medicines and Healthcare products Regulatory Agency.
Sir John, Oxford University's regius professor of medicine, told BBC Radio 4's Today programme that he expects MHRA approval "pretty shortly".
"They got data quite a long time ago but that was the first set of data,” he said. "They receive multiple sets of data.
"So we are getting to be about prime time now, I would expect some news pretty shortly.
"I doubt we'll make Christmas now, but just after Christmas I would expect.
"I have no concerns whatsoever that the data looks better than ever."
"This is the next step towards a decision on the deployment of the vaccine," the health minister Hancock added at a press conference where he announced Britain would impose travel restrictions on South Africa to curb the spread of another new, more transmissible strain of the coronavirus.
The Pfizer/BioNTech vaccine was the first coronavirus shot to be authorised for use by the UK's independent medicines regulator and has been given to 500,000 of the country's most vulnerable people since its rollout last month.
The bulk of Britain's vaccine requirements are expected to be met by the jab developed by AstraZeneca and the University of Oxford, as the government has ordered 100 million doses.
Meet Kiwi shot putter Valerie Adams who swung back to action at 36 after two children and three critical abdominal surgeries to win an Olympic Bronze
This is the first study to show that persistent lack of sleep is a strong predictor of psychosis
International passenger traffic increased by 20 per cent in March 2024
In addition to citizens from the newly included countries, the tourist visa has been extended to seven other categories
Al-Najjar, one of the three hospitals in Rafah, is no longer functioning due to the ongoing hostilities in the vicinity and the military operation in Rafah
The tweet also informed people of the different details that a single ID card can provide
Airport expected to increase its capacity to 25 million passengers annually by 2027
Core taxi segment revenue up 15% year-on-year